Supernus Pharmaceuticals (SUPN) Gross Profit (2013 - 2026)
Supernus Pharmaceuticals (SUPN) reported Gross Profit of $185.39 million for Q2 2026, up 24.7% from $148.63 million a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Gross Profit (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Supernus Pharmaceuticals' Gross Profit came in at $695.72 million, up 18.1% year-over-year; for FY2025, it came in at $644.39 million, up 10.4% from FY2024.
- Gross Profit has a five-year compound annual growth rate of 6.6% (FY2020 to FY2025).
- By year, Gross Profit came in at $583.91 million in FY2024 (+11.5%), $523.74 million in FY2023 (-9.7%), $580.02 million in FY2022 (+14.9%) and $504.71 million in FY2021 (+7.9%).
- Five-year quarterly Gross Profit spans a low of $114.47 million in Q2 2023 and a high of $188.57 million in Q4 2025.
- Year over year, Gross Profit gained in six of the last seven quarters, with growth averaging 12.3%.
- The high point for year-over-year Gross Profit in five years was Q2 2024 (growth of 31.4%); the low point was Q2 2023 (a decline of 23.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Supernus Pharmaceuticals | 2.47 Bn | 1.12 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 185.39 Mn |
| Dec 31, 2025 | 188.57 Mn |
| Sep 30, 2025 | 173.14 Mn |
| Jun 30, 2025 | 148.63 Mn |
| Mar 31, 2025 | 134.06 Mn |
| Dec 31, 2024 | 148.06 Mn |
| Sep 30, 2024 | 158.11 Mn |
| Jun 30, 2024 | 150.41 Mn |
| Mar 31, 2024 | 127.34 Mn |
| Dec 31, 2023 | 144.69 Mn |
| Sep 30, 2023 | 134.28 Mn |
| Jun 30, 2023 | 114.47 Mn |
| Mar 31, 2023 | 130.30 Mn |
| Dec 31, 2022 | 144.37 Mn |
| Sep 30, 2022 | 151.48 Mn |
| Jun 30, 2022 | 149.59 Mn |
| Mar 31, 2022 | 134.57 Mn |
| Dec 31, 2021 | 142.06 Mn |
| Sep 30, 2021 | 130.38 Mn |
| Jun 30, 2021 | 116.30 Mn |
API Access
Supernus Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();